Last update 02 Aug 2025

mRNA COVID-19 Vaccine(LiveRNA Therapeutics Inc.)

Overview

Basic Info

Drug Type
Prophylactic vaccine, mRNA vaccine
Synonyms
a bivalent mRNA vaccine with Delta/BA.5 combination(LiveRNA Therapeutics), mRNA COVID-19 Vaccine(AIM Vaccine), SARS-CoV-2 mRNA Vaccine
+ [3]
Action
inhibitors
Mechanism
SARS-CoV-2 S protein inhibitors(SARS-CoV-2 S protein inhibitors)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Severe Acute Respiratory SyndromePhase 3
Kenya
30 Jan 2023
COVID-19Phase 3
China
08 Apr 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
-
(成人中剂量组)
sqpjikciju(uewojvjhhi) = 整体上与疫苗接种有关的不良反应以1级为主,无相关的严重不良事件(SAE)或特殊关注的不良事件,疫苗安全风险低 lnkzijqlyr (vifffjwmqn )
Positive
24 Aug 2022
(成人高剂量组)
Not Applicable
Renal transplant rejection
serum creatinine | proteinuria | anti-RBD antibodies ...
58
mRNA-BNT162b2 vaccine
opdhjuxpvq(tkdobodarw) = There were no severe adverse events or deaths during follow-up myitnzuflj (qvgkhttmnr )
Positive
27 Oct 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free